Facial nerve outcomes in middle cranial fossa vs translabyrinthine approaches
- PMID: 16360512
- DOI: 10.1016/j.otohns.2005.08.021
Facial nerve outcomes in middle cranial fossa vs translabyrinthine approaches
Abstract
Objective: To compare the final facial nerve outcomes between middle cranial fossa (MCF) vs translabyrinthine (TL) resection of size-matched vestibular schwannomas.
Study design and setting: Retrospective case review at a tertiary care hospital. All patients who underwent resection utilizing either MCF or TL approaches with tumors 18 mm or smaller and complete data were included in the analysis. One hundred twenty-four patients were identified meeting the above criteria, with sixty-three in the translabyrinthine group and sixty-one in the middle fossa group. One-week-postoperative and final facial nerve examinations were compared in the two surgical groups. Patients were separately analyzed in subgroups: tumors smaller than 10 mm and those that were between 10 and 18 mm.
Results: The tumor size range for the MCF group was 3-18 mm while it was 4-18 mm for the TL group. No statistically significant difference was found in facial nerve outcomes between the two surgical groups, at the first postoperative visit week and at last follow-up.
Conclusion: Facial nerve outcomes are similar using TL and MCF approaches for resection of vestibular schwannomas up to 18 mm in size.
Significance: Patients undergoing the MCF approach for hearing preservation can be counseled that there is no increased risk of permanent facial nerve weakness, compared to the TL approach.
Similar articles
-
Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center.Laryngoscope. 2007 Dec;117(12):2087-92. doi: 10.1097/MLG.0b013e3181453a07. Laryngoscope. 2007. PMID: 17921903
-
Hearing preservation and facial nerve outcomes in vestibular schwannoma surgery: results using the middle cranial fossa approach.Otol Neurotol. 2006 Feb;27(2):234-41. doi: 10.1097/01.mao.0000185153.54457.16. Otol Neurotol. 2006. PMID: 16436995
-
Comparison of facial nerve function results after translabyrinthine and retrosigmoid approach in medium-sized tumors.Arch Otolaryngol Head Neck Surg. 2003 Apr;129(4):429-31. doi: 10.1001/archotol.129.4.429. Arch Otolaryngol Head Neck Surg. 2003. PMID: 12707190
-
Surgical management of jugular foramen schwannomas with hearing and facial nerve function preservation: a series of 23 cases and review of the literature.Laryngoscope. 2006 Dec;116(12):2191-204. doi: 10.1097/01.mlg.0000246193.84319.e5. Laryngoscope. 2006. PMID: 17146395 Review.
-
Retrosigmoid versus middle fossa surgery for small vestibular schwannomas.Laryngoscope. 2004 Aug;114(8):1455-61. doi: 10.1097/00005537-200408000-00026. Laryngoscope. 2004. PMID: 15280726 Review.
Cited by
-
Outcome on hearing and facial nerve function in microsurgical treatment of small vestibular schwannoma via the middle cranial fossa approach.Eur Arch Otorhinolaryngol. 2013 Mar;270(4):1209-16. doi: 10.1007/s00405-012-2074-8. Epub 2012 Jun 22. Eur Arch Otorhinolaryngol. 2013. PMID: 22722943
-
Clinical Studies and Pre-clinical Animal Models on Facial Nerve Preservation, Reconstruction, and Regeneration Following Cerebellopontine Angle Tumor Surgery-A Systematic Review and Future Perspectives.Front Bioeng Biotechnol. 2021 Jun 18;9:659413. doi: 10.3389/fbioe.2021.659413. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34239858 Free PMC article.
-
Value of free-run electromyographic monitoring of lower cranial nerves in endoscopic endonasal approach to skull base surgeries.J Neurol Surg B Skull Base. 2012 Aug;73(4):236-44. doi: 10.1055/s-0032-1312712. Epub 2012 May 25. J Neurol Surg B Skull Base. 2012. PMID: 23904999 Free PMC article.
-
What is the best tumor size to achieve optimal functional results in vestibular schwannoma surgery?Skull Base. 2008 Sep;18(5):317-25. doi: 10.1055/s-0028-1086056. Skull Base. 2008. PMID: 19240831 Free PMC article.
-
A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311.Oral Oncol. 2020 Nov;110:104797. doi: 10.1016/j.oraloncology.2020.104797. Epub 2020 Jul 14. Oral Oncol. 2020. PMID: 32679405 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical